<!--<?xml version="1.0" encoding="UTF-8"?>-->
<?xml-stylesheet type="text/css" href="https://admin.imcjms.com/assets/rss.css" ?><rss version="2.0">

    <channel>

        <title>IMC Journal of Medical Science</title>
        <link>https://admin.imcjms.com/ </link>
        <description>Ibrahim Medical College Journal of Medical Science</description>

                        <item>
                    <title><![CDATA[Dengue and Chikungunya virus co-infection in
fever cases attending a tertiary care hospital in Dhaka city]]></title>
                    <author>Saika Farook</author><author>Farhan Muhib</author><author>Maisha Islam</author><author>Md. Faizul Ahasan</author><author>Aunta Melan</author><author>Sadia Islam</author><author>Md. Shariful Alam Jilani*</author>                    <link> https://admin.imcjms.com/registration/journal_full_text/619 </link>
                    <pubDate>2026-10-19 10:17:34</pubDate>
                    <category>Brief Research Note</category>
                    <comments>July 2026; Vol. 20(2):005</comments>
                    <description>
                        <![CDATA[Abstract
Background
and objectives: Dengue virus (DENV) and chikungunya
virus (CHIKV) are important Aedes-borne arboviruses that frequently
co-circulate in tropical regions, posing diagnostic and public health
challenges because of their overlapping clinical features. This study
investigated the prevalence and distribution pattern of dengue, chikungunya,
and their co-infection among clinically suspected arboviral febrile cases
attending a tertiary care hospital in Dhaka city, Bangladesh.
Materials and methods: Patients with acute fever attending both
the in and out-patient departments of a tertiary care hospital in Dhaka city between July and September 2025were included in the
study. Serum samples were tested for DENV (dengue virus), CHIKV (chikungunya
virus) and ZIKV (zika virus) by real time multiplex RT-PCR. Demographic data of patients were
collected from the hospital register.
Results: A total of 970 acute
febrile cases were included in the study. CHIKV was detected in 557 (57.4%), DENV
in 71 (7.3%), and DEN–CHIK co-infection in 15 (1.5%) patients, while 327
(33.7%) patients tested negative. CHIK infection predominated during July and
August, whereas DEN infection increased significantly in September.
Co-infection was uncommon but peaked in August. Male patients had significantly
higher rates of CHIK infection and co-infection than females, while no
significant age-related differences were observed. 
Conclusions:
The low
co-infection rate of DENV and
CHIKV in our study is comparable to reports from
other endemic countries, suggesting limited temporal overlap of DENV and CHIKV transmission
despite their co-circulation. These findings highlight the value of integrated
arboviral surveillance for accurate diagnosis, timely outbreak detection, and
effective public health interventions in Bangladesh.
July 2026; Vol.
20(2):005. DOI: https://doi.org/10.55010/imcjms.20.014
*Correspondence: Prof. Md. Shariful Alam Jilani, Department of
Microbiology, Ibrahim Medical College. Email: jilanimsa@gmail.com
© 2026 The Author(s). This is an open access article
distributed under the terms of the Creative Commons Attribution License(CC BY 4.0)
Introduction
The clinical manifestations of dengue (DEN) and chikungunya (CHIK)
infections frequently overlap, especially in the acute febrile phase. Fever,
headache, myalgia, rash, arthralgia, and malaise are common to both diseases,
making syndromic differentiation difficult without laboratory confirmation.
However, the clinical implications differ- dengue may progress to plasma
leakage, hemorrhage, organ involvement, and shock, whereas CHIK infection is
more characteristically associated with severe and often prolonged arthralgia
and post-viral disability [1]. In settings where both viruses
co-circulate, co-infection can occur when an individual is infected
with both pathogens concurrently or within a short interval. Although reported
less commonly than mono-infection, dengue–chikungunya co-infection is
epidemiologically important because it may confound diagnosis, influence
symptom profile and severity, and complicate patient management and
surveillance interpretation. 
Bangladesh provides a highly suitable ecological setting for the
co-circulation of these arboviruses. Rapid urbanization, high population
density, inadequate water management, unplanned construction, monsoon rainfall,
and widespread vector breeding opportunities have facilitated repeated Aedes-associated
outbreaks. Dengue has been recognized in Bangladesh since the major nationwide
epidemic of 2000 and has since evolved from an episodic urban disease into a
recurrent and increasingly widespread national public health problem [3]. Large
DENV surges have been documented in 2018, 2019, 2021, 2022, and especially
2023, when Bangladesh experienced its largest recorded DEN outbreak [1]. The 2025 DENV outbreak in
Bangladesh reflects a notable epidemiological shift, with continuous
transmission occurring throughout the year rather than being confined to the
usual June–November season. The
case fatality rate (CFR) in 2025 was 0.40% (412 deaths among 102,562 cases) [4].
Despite this growing risk, there remains limited epidemiologic evidence
from Bangladesh characterizing the relative contribution of DEN, CHIK, and
DEN-CHIK co-infection among acute febrile patients, and even fewer studies have
examined how these distributions vary by age, sex, and seasonality. Such
information is essential for addressing clinical suspicion, improving
laboratory testing strategies, and informing vector-control planning.
 
Materials and
methods
This retrospective, cross-sectional study
was conducted at a tertiary care hospital of Dhaka city between July 2025 to September
2025. Patients with fever attending both the in and out-patient departments,
from different locales, mostly within but also beyond Dhaka city, were included
in the study. 
Serum samples from fever cases were
tested for DENV (dengue virus), CHIKV (chikungunya virus) and ZIKV (zika virus)
by real time multiplex RT-PCR. Viral RNA was
extracted from serum using a column-based viral nucleic acid extraction kit (Qiagen
N.V, Germany) following the manufacturer’s specifications. Viral RNA was
amplified using Bioperfectus zika virus, dengue virus and chikungunya virus
Real Time PCR kit (Jiangsu Bioperfectus Technologies Co. Ltd., China), in
accordance with the thermal profile recommended by the manufacturer. The assay
utilizes polyprotein gene region of ZIKV, 3ˈUTR region of DENV and NSP1 region
of CHIKV as PCR targets, and cycle threshold (Ct) value ≤40 for any of the
targets was considered as positive.
Demographic
data of patients were collected from the hospital register. Data were analyzed with Statistical Product for
Service Solutions (SPSS) software (IBM SPSS Statistics for Windows, version
20.0).
 
Results
A total of 970 febrile cases
were included during the study period (July–September 2025), of which557 (57.4%) were CHIK-positive,
71 (7.32%) DEN-positive, and 15(1.55%) were positive for both CHIK and DEN infections
(Table-1).
Chikungunya
accounted for nearly half to two-thirds of cases across all age groups, highest
in 18–40 years (58·5%) and >40 years (58·1%), compared with <18 years
(48·8%). Dengue represented a smaller proportion within each age group, peaking
at 9% in those aged 18–40 years, while co-infection remained low (≤1·7%).
Differences across age groups were not statistically significant.
 
Table: Distribution
of RT-PCR–confirmed chikungunya (CHIKV) and dengue (DENV) infections (n=970)
 
 
Significantly greater proportion of males
had CHIK compared with females (59·6% vs 54·9%; p=0·036), and co-infection was
also significantly higher among males (2·5% vs 0·4%; p=0·008), whereas dengue
proportions were similar between both sexes (p=0·089).
Majority of CHIK cases presented in July
(60·1%) and peaked in August (68·1%) before declining in September (45·7%;
p<0·001). In contrast, DEN infection represented a small proportion in July
and August (~3%) but increased significantly in September (13·4%; p<0·001).
Co-infection peaked in August (2·7%; p=0·030). Overall, temporal variation and
sex, but not age, were significantly associated with infection distribution.
Among the 15 patients listed
in the separate co-infection dataset, platelet counts were available for 13
patients (86.7%). Using a reference range of 150-450×10⁹/L
for platelet count [7], 5 of the 13 patients (38.5%) had platelets counts below
the lower reference limit. The remaining eight patients (61.5%)hadplateletcountswithinorabovethereferencerange. The lowest recorded count was 40×10⁹/L,
indicating marked thrombocytopenia in at least one co-infected patient.
 
Discussion
The occurrence of DEN-CHIK
co-infection has been recognized for more than six decades. The earliest
documented cases were reported in Thailand by Nimmannitya et al.,
who identified4 co-infected
patients among 150 individualswith either DEN or CHIK during
1962–1964, corresponding to a co-infection rate of2.6% [8]. Since then, sporadic and
outbreak-associated co-infections have been reported from several endemic
countries. A large outbreak inPunjab, India,
in 2009 reported a remarkably higher co-infection rate of54%, reflecting intense simultaneous
transmission of both viruses [9]. Outside Asia, co-infections have also been
documented in Africa and the Middle East. During an outbreak in Gabon,
8 of 773 patients (1.0%)were confirmed to have concurrent DEN
and CHIK infections [10]. Similarly, in Al Hudaydah,
Yemen,13 of 400
patients (3.3%) were
diagnosed with DEN–CHIK co-infection during the 2012 outbreak [11]. These
studies collectively demonstrate that although DEN–CHIK co-infection has been
recognized for decades, its prevalence varies widely across geographical
regions and outbreaks, ranging from less than 1% to more than 50%, depending on
local transmission dynamics, vector abundance, timing of epidemics, and the laboratory
methods used for diagnosis.
In the present study, the
prevalence of DEN–CHIK co-infection was1.5% (15/970),
which is comparable to the relatively low rates reported from Thailand (2.6%),
Gabon (1.0%), Yemen (3.3%), and Vellore (0.2%) [8,10-11] but substantially
lower than the unusually high prevalence observed during the Punjab outbreak [9].
The low frequency of co-infection in our study may be explained by the
differing epidemiology of the two viruses during the study period. Although
both viruses were circulating concurrently in Bangladesh, CHIKV predominated
during July and August, whereas DEN cases increased sharply in September,
resulting in only a limited period of overlapping transmission. Furthermore,
differences in viral transmission dynamics, mosquito infection rates, seasonal
variation, vector competence, host immunity, healthcare-seeking behaviour, and
study design may have influenced the likelihood of simultaneous infection. The
use of multiplex real-time RT-PCR in the present study also ensured laboratory
confirmation of acute infections, minimizing misclassification and providing a
more accurate estimate of the true burden of co-infection compared with studies
relying solely on serological assays.
The higher proportion of CHIKV
in July–August followed by a rise in DENV in September suggests aclassical seasonal pattern with sequential dominance,
where ecological conditions during early monsoon may favor CHIKV transmission,
and later conditions (e.g., increased vector density, viral amplification, or
herd immunity shifts) facilitate DENV predominance. This indicates thatco-circulating arboviruses do not necessarily peak simultaneously
but may alternate in dominance within the same season. This is biologically
plausible in Bangladesh, where monsoon rainfall, temperature, vector density,
and urban breeding conditions strongly influence the transmission of Aedes
mosquito [3]. However, in case of DENV, a recent reporting of 24,535 cases in
November and 8,165 in December months, typically considered low-risk months,
suggests while peak transmission remains seasonally structured, DENV
transmission is no longer strictly confined to the mid-monsoon period only
(mid- June to mid-August). Instead, there appears to be a prolonged tail of transmission
extending into traditionally low-risk months [3]. Althoughco-infection was infrequent, its
detection is epidemiologically important. Since DENV and CHIKV share the same
principal vectors, Aedes
aegyptiandAedes
albopictus, co-infection is expected wherever both viruses
co-circulate [3]. Furuya-Kanamori et al. revealed that reported co-infection
likely underestimates the true burden because many suspected arboviral cases
are tested for only one pathogen [12]. The said article reported that 13 out of
98 countries or territories have been identified to report DEN and CHIK co-infection
[12].
In this study,age was not significantly associated with
infection distribution, indicating that exposure was relatively broad across
age groups. By contrast, males had a significantly higher proportion of CHIK and DEN-CHIK
co-infection, which may reflect differences inmobility, occupational exposure, and daytime contact with
Aedes mosquitoes, which are predominantly day-biting [3].
Similar sex-related variation has been inconsistently
reported elsewhere, suggesting that this may be influenced bylocal epidemiologic and behavioral factors rather than a universal pattern [1].
 
Cite this article
as:
Farook S, Muhib F, Islam M, Ahasan MF,
Melan A, Islam S, et al. Dengue and Chikungunya virus co-infection in fever
cases attending a tertiary care hospital in Dhaka city. IMC J Med Sci. 2026;
20(2):005. DOI:https://doi.org/10.55010/imcjms.20.014]]>
                    </description>
                </item>
            
        
    </channel>

    <copyright>2026 Ibrahim Medical College. All rights reserved.</copyright>

</rss>
